PDPN and neoplasm: Furthermore, administration of humLpMab-23-f in tumor-bearing mice completely suppressed the growth of CHO/PDPN xenografts (Figure 3A,C,E) and exerted potent antitumor effects in PC-10 and LN319 xenografts (Figure 5).